Novartis AG (NVS) – Bullish Recovery with Key Levels to WatchAnalysis Overview:
Novartis AG has shown a strong recovery, bouncing back from its recent low near $91.84, a key support level that held well. The stock is now trading at $103.29 (+3.32%), approaching its mid-term moving averages, signaling renewed momentum.
Key Levels:
Support: $91.84 (Strong bas
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6.43 USD
11.94 B USD
50.32 B USD
1.90 B
About NOVARTIS N
Sector
Industry
CEO
Vasant Narasimhan
Website
Headquarters
Basel
Founded
1996
FIGI
BBG000LYF3S8
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US66989HAS7
NOVARTIS CAP 20/50Yield to maturity
6.75%
Maturity date
Aug 14, 2050
XPND
NOVARTIS CAPITAL 15/45Yield to maturity
5.92%
Maturity date
Nov 20, 2045
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042Yield to maturity
5.84%
Maturity date
Sep 21, 2042
US66989HAH1
NOVARTIS CAPITAL 14/44Yield to maturity
5.75%
Maturity date
May 6, 2044
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054Yield to maturity
5.74%
Maturity date
Sep 18, 2054
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034Yield to maturity
5.05%
Maturity date
Sep 18, 2034
XPNC
NOVARTIS CAPITAL 15/25Yield to maturity
4.71%
Maturity date
Nov 20, 2025
US66989HAR9
NOVARTIS CAP 20/30Yield to maturity
4.46%
Maturity date
Aug 14, 2030
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031Yield to maturity
4.40%
Maturity date
Sep 18, 2031
NVS5894398
Novartis Capital Corp. 3.8% 18-SEP-2029Yield to maturity
4.16%
Maturity date
Sep 18, 2029
NVS4950565
Novartis Capital Corp. 2.0% 14-FEB-2027Yield to maturity
4.15%
Maturity date
Feb 14, 2027
See all NVS bonds
Curated watchlists where NVS is featured.